These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1868471

  • 1. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
    Theodorescu D, Cornil I, Sheehan C, Man MS, Kerbel RS.
    Cancer Res; 1991 Aug 15; 51(16):4486-91. PubMed ID: 1868471
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM.
    Cancer Res; 1990 Apr 15; 50(8):2530-7. PubMed ID: 1690599
    [Abstract] [Full Text] [Related]

  • 3. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H, Azuma M, Kameyama S, Nan L, Oyasu R.
    Cell Growth Differ; 1992 Nov 15; 3(11):819-25. PubMed ID: 1467309
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 15; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK.
    Urol Oncol; 2004 Sep 15; 22(2):93-101. PubMed ID: 15082004
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LW.
    Cancer Res; 1993 Nov 01; 53(21):5300-7. PubMed ID: 8221665
    [Abstract] [Full Text] [Related]

  • 7. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov 15; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
    Minke JM, Schuuring E, van den Berghe R, Stolwijk JA, Boonstra J, Cornelisse C, Hilkens J, Misdorp W.
    Cancer Res; 1991 Aug 01; 51(15):4028-37. PubMed ID: 1649697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 17. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW, Lykkesfeldt AE, Laursen I, Nielsen KV, Briand P.
    Cancer Res; 1992 Mar 01; 52(5):1210-7. PubMed ID: 1737382
    [Abstract] [Full Text] [Related]

  • 18. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.
    Martínez-Lacaci I, De Santis M, Kannan S, Bianco C, Kim N, Wallace-Jones B, Wechselberger C, Ebert AD, Salomon DS.
    J Cell Physiol; 2001 Feb 01; 186(2):233-42. PubMed ID: 11169460
    [Abstract] [Full Text] [Related]

  • 19. Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.
    Dinney CP, Parker C, Dong Z, Fan D, Eve BY, Bucana C, Radinsky R.
    Clin Cancer Res; 1997 Feb 01; 3(2):161-8. PubMed ID: 9815668
    [Abstract] [Full Text] [Related]

  • 20. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 Feb 01; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.